Abstract
Our gene expression-profiling analysis aimed to explain the mechanism of breast cancer development by identifying key pathways and constructing networks of related transcription factors (TFs) and microRNAs (miRNAs) in breast cancer tissues. Gene expression profiles of normal and breast cancer tissues were downloaded to identify differentially expressed genes (DEGs). Coexpression modules were explored using weighted gene coexpression network analysis (WGCNA). Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses were performed to discover the enriched functionally associated gene groups and define pathways in breast cancer, respectively. miRNAs-DEGs and TF-DEG regulatory networks were constructed using Cytoscape. CDK6(cyclin-dependent kinase), miR-124, EGF(epidermal growth factor) and NF-κB(nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) expression was also analyzed using real-time quantitative PCR. Totally, 7713 DEGs were identified for WGCNA. The results revealed that 1388 upregulated DEGs were associated with protein transport, protein localization and organic substance transport, whereas 1819 downregulated DEGs were associated with cancer and Wnt signaling pathways. Five miRNAs (miR-760, miR-1276, miR-124, miR-124-3p and miR-506-3p) with a degree of ⩾15 and one important TF (NF-κB) were identified in miRNA and TF regulatory networks. CDK6 mRNA and miR-124 expression was significantly reduced and EGF mRNA expression was clearly enhanced in cancer tissues compared with those in normal breast tissues. The CDK6 gene could be regulated by miR-124, which is involved in Wnt signaling and cancer pathways. NF-κB might initiate the breast cancer pathway by targeting EGF in human breast cancer tissues. This putative information on regulatory networks in breast cancer will be beneficial for future researches on mechanisms underlying its development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Siegel R, Naishadham D, Jemal A . Cancer statistics. 2013. CA Cancer J Clin 2013; 63: 11–30.
Newman LA, Kuerer HM . Advances in breast conservation therapy. J Clin Oncol 2005; 23: 1685–1697.
Jemal A, Bray F, Center M, Ferlay J, Ward E . Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
Song SJ, Poliseno L, Song MS, Ala U, Webster K, Ng C et al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 2013; 154: 311–324.
Marusyk A, Polyak K . Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 2010; 1805: 105–117.
Almendro V, Fuster G . Heterogeneity of breast cancer: etiology and clinical relevance. Clin Transl Oncol 2011; 13: 767–773.
Liu S, Dontu G, Wicha MS . Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res 2005; 7: 86–95.
Van De Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999–2009.
Reis-Filho JS, Pusztai L . Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet 2011; 378: 1812–1823.
Ferracin M, Lupini L MicroRNA expression profiling and its clinical impact in breast cancer. In: MicroRNAs: Key Regulators of Oncogenesis. Springer: Switzerland, 2014, pp 355–367..
Buerger H, Boecker F, Packeisen J, Agelopoulos K, Poos K, Nadler W et al. Analyzing the basic principles of tissue microarray data measuring the cooperative phenomena of marker proteins in invasive breast cancer. Open Access Bioinformatics 2013; 5: 1–21.
Prat A, Adamo B, Cheang MC, Anders CK, Carey LA, Perou CM . Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. Oncologist 2013; 18: 123–133.
Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297.
He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828–833.
Ma L, Teruya-Feldstein J, Weinberg RA . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682–688.
Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, Sabbioni S et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065–7070.
Fu J, Allen W, Xia A, Ma Z, Qi X . Identification of biomarkers in breast cancer by gene expression profiling using human tissues. Genom Data 2014; 2: 299–301.
Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S et al. Functional organization of the transcriptome in human brain. Nat Neurosci 2008; 11: 1271–1282.
Langfelder P, Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008; 9: 559.
Smyth GK . Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3Article 3. e-pub ahead of print 12 February 2004.
Zhang B, Horvath S . A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 2005; 4Article17. E-pub ahead of print 12 August 2005.
Horvath S, Zhang B, Carlson M, Lu K, Zhu S, Felciano R et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci USA 2006; 103: 17402–17407.
Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M . The KEGG resource for deciphering the genome. Nucleic Acids Res 2004; 32 (suppl 1): D277–D280.
Consortium GO. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004; 32 (suppl 1): D258–D261.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498–2504.
Pimentel-Santos FM, Ligeiro D, Matos M, Mourão AF, Costa J, Santos H et al. Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects. Arthritis Res Ther 2011; 13: R57.
Zhang B, Pan X, Cobb GP, Anderson TA . microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1–12.
Lv XB, Jiao Y, Qing Y, Hu H, Cui X, Lin T et al. miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro. Chin J Cancer 2011; 30: 821–830.
Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, Yu XT et al. MiR-124 targets slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 2013; 34: 713–722.
Lv Z, Yang L . MiR-124 inhibits the growth of glioblastoma through the downregulation of SOS1. Mol Med Rep 2013; 8: 345–349.
Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setién F et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007; 67: 1424–1429.
Grossel MJ, Hinds PW . Beyond the cell cycle: a new role for Cdk6 in differentiation. J Cell Biochem 2006; 97: 485–493.
Benhaj K, Akcali KC, Ozturk M . Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 2006; 15: 701–707.
Cover CM, Hsieh SJ, Tran SH, Hallden G, Kim GS, Bjeldanes LF et al. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 1998; 273: 3838–3847.
Bjeldanes LF, Kim J-Y, Grose KR, Bartholomew JC, Bradfield CA . Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci USA 1991; 88: 9543–9547.
Vickers PJ, Dickson RB, Shoemaker R, Cowan KH . A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Mol Endocrinol 1988; 2: 886–892.
Monteiro P, Gilot D, Le Ferrec E, Rauch C, Lagadic-Gossmann D, Fardel O . Dioxin-mediated up-regulation of aryl hydrocarbon receptor target genes is dependent on the calcium/calmodulin/CaMKIalpha pathway. Mol Pharmacol 2008; 73: 769–777.
Zhang Y, Zheng L, Huang J, Gao F, Lin X, He L et al. MiR-124 radiosensitizes human colorectal cancer cells by targeting PRRX1. PLoS ONE 2014; 9: e93917.
Arora H, Qureshi R, Park W-Y . miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines. PLoS ONE 2013; 8: e64273.
Wen SY, Lin Y, Yu YQ, Cao SJ, Zhang R, Yang XM et al. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer. Oncogene 2014; 34: 717–725.
Liu G, Fang Y, Zhang H, Li Y, Li X, Yu J et al. Computational identification and microarray-based validation of microRNAs in Oryctolagus cuniculus. Mol Biol Rep 2010; 37: 3575–3581.
King MC, Marks JH, Mandell JB . Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302: 643–646.
Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L et al. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS ONE 2012; 7: e44398.
Acknowledgements
This work was supported by Expression of TNC in Ovarian Cancer Cells and its Resistance to Chemotherapy (Program No. H201450).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Guo, X., Xiao, H., Guo, S. et al. Identification of breast cancer mechanism based on weighted gene coexpression network analysis. Cancer Gene Ther 24, 333–341 (2017). https://doi.org/10.1038/cgt.2017.23
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2017.23
This article is cited by
-
Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis
BMC Cancer (2021)
-
Protein co-expression networks identified from HOT lesions of ER+HER2–Ki-67high luminal breast carcinomas
Scientific Reports (2021)
-
Disease-related cellular protein networks differentially affected under different EGFR mutations in lung adenocarcinoma
Scientific Reports (2020)
-
Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico
Hereditas (2019)
-
The synthetic histone-binding regulator protein PcTF activates interferon genes in breast cancer cells
BMC Systems Biology (2018)